Pharma C Investments - Notice of AGM

For best results when printing this announcement, please click on link below:
http://newsfile.refinitiv.com/getnewsfile/v1/story?guid=urn:newsml:reuters.com:20221124:nRSX5541Ha&default-theme=true

RNS Number : 5541H  Pharma C Investments PLC  24 November 2022

24 November 2022

 

Pharma C Investments PLC

("Pharma C" or the "Company")

Notice of AGM

 

Pharma C Investments (AQSE: PCIL), an early-stage investor and venture builder
in the medical cannabis industry with a particular focus on companies that
provide ancillary products and services to the medicinal cannabis sectors,
announces that further to the announcement of 18 November 2022, the Annual
General Meeting will now be held at 11am on Tuesday 20(th) December at the
offices of Hill Dickinson LLP. Notice will be posted to shareholders today and
will also be available on the company's website.

 

 

The Directors of the Company accept responsibility for the contents of this
announcement.

 

For further information please visit www.pharmacinvestments.com
(http://www.pharmacinvestments.com/)

 

For additional information please contact:

 

Pharma C Investments

Gavin Sathianathan, Investment Strategy Director

gavin@pharmacinvestments.com

 

Novum Securities

 

(AQSE Corporate Adviser)

 

Tel: +44 207 399 9400

 

David Coffman

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact
rns@lseg.com (mailto:rns@lseg.com)
 or visit
www.rns.com (http://www.rns.com/)
.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our
Privacy Policy (https://www.lseg.com/privacy-and-cookie-policy)
.   END  NEXFELFMLEESEIF

Recent news on Sentry 7

See all news